Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition

Journal of Immunology

Volumn 156, Issue 2, 1996, Pages 818-825

  Daw, Kendra ^a   Ujihara, Noriko ^a   Atkinson, Mark ^b   Powers, Alvin C ^a,c  

^a VANDERBILT UNIVERSITY   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; EPITOPE; GLUTAMATE DECARBOXYLASE;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; AUTOIMMUNITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; STIFF MAN SYNDROME;

AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; DIABETES MELLITUS, TYPE 1; EPITOPES; GLUTAMATE DECARBOXYLASE; HUMANS; PEPTIDE FRAGMENTS; PRECIPITIN TESTS; PREDIABETIC STATE; RECOMBINANT FUSION PROTEINS; RISK; STIFF-PERSON SYNDROME;

EID: 0030028799     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Castano, L , and G. S. Eisenbarth 1990. Type-I diabetes: a chrome autoimmune disease of human, mouse, and rat. Annu. Rev. Immunol. 8:647.
2. Clare-Salzler, M J , A J Tobin, and D. L. Kaufman. 1992. Glutamate decarboxylase: an autoantigen in IDDM. Diabetes Care 15:132.
3. Solimena, M., and P. De Camilli. 1991. Autoimmunity to glutamic acid decarboxylase (GAD) in stiff-man syndrome and insulin-dependent diabetes mellitus. Trends Neurosci. 14.452.
4. Erlander, M. G , and A. J. Tobin. 1991. The structural and functional heterogeneity of glutamic acid decarboxylase: a review. Neurochem. Res. 16:215.
5. Reetz, A , M Solimena, M. Matteoli, F. Folli, K Takei, and P. De Camilli 1991 GABA and pancreatic beta-cells, colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic-like microvesicles suggests their role in GABA storage and secretion EMBO J. 10:1275.
6. Bu, D. F., M G Erlander, B. C. Hitz, N. J. Tillakaratne, D. L. Kaufman, C. B. Wagner-McPherson, G. A Evans, and A. J. Tobin. 1992 Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are encoded by a single gene. Proc. Natl. Acad. Sci. USA 89:2115.
7. Solimena, M., D. Aggujaro, C. Muntzel, R Dirkx, M. Butler, P. De Camilli, and A. Hayday. 1993 Association of GAD-65, but not of GAD-67, with the Golgi complex of transfected Chinese hamster ovary cells mediated by the N-terminal region. Proc. Natl. Acad. Sci. USA 90:3073.
8. Petersen, J. S., S. Russel, M. O. Marshall, H Kofod, K. Buschard, N. Cambon, A. E. Karlsen, E. Boel, W. A. Hagopian, K. R. Hejnaes, A. Moody, T. Dyrberg, A. Lernmark, O. D Madsen, and B. K Michelson. 1993. Differential expression of glutamic acid decarboxylase in rat and human islets. Diabetes 42:484.
9. Kim, J , W Richter, H. J. Aanstoot, Y. Shi, Q Fu, R. Rajotte, G. Warnock, and S. Baekkeskov. 1993 Differential expresssion of GAD 65 and GAD 67 in human, rat, and mouse pancreatic islets Diabetes 42:1799
10. Baekkeskov, S., H J. Aanstoot, S. Christgau, A. Reetz, M Solimena, M. Cascalho, F. Folli, H. Richter-Olesen, and P. DeCamilli. 1990 Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase Nature 347:151.
11. Hagopian, W A , A E. Karlsen, A. Gottsater, M. Landin-Olsson, C. E. Grubin, G. Sundkvist, J S. Petersen, E. Boel, T. Dyrberg, and A. Lernmark 1993. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type. J. Clin. Invest. 91:368.
12. Rowley, M J , I. R Mackay, Q. Y Chen, W J. Knowles, and P Z. Zimmet 1992. Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus Diabetes 41.548.
13. De Aizpurua, H J , Y M. Wilson, and L. C. Harrison. 1992. Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes. Proc. Natl. Acad. Sci. USA 89 9841.
14. Honeyman, M. C , D S Cram, and L C. Harrison. 1993. Glutamic acid decarboxylase 67-reactive T cells a marker of insulin-dependent diabetes. J. Exp. Med. 177.535.
15. Atkinson, M. A., D. Kaufman, L. Campbell, K. A. Gibbs, S. C. Shah, D. F Bu, M. G. Erlander, A. J. Tobin, and N. K. Maclaren. 1992. Response of peripheral blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 339:458.
16. Kaufman, D. L., M J. Clare-Salzler, J. Tian, T. Forsthuber, G. S. P. Ting, P Robinson, M, A Atkinson, E. E. Seroarz, A J. Tobin, and P. V. Lehman. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69.
17. Tisch, R., Y D. Yang, S. M. Singer, R. S. Liblau, L. Fugger, and H. O. McDevitt. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366:72.
18. Bjork, E , L. A Velloso, O. Kampe, and F. A. Karlsson 1994. GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes. Diabetes 43:161.
19. Butler, M. H., M. Solimena, R. Dirkx, A Hayday, and P. De Camilli. 1993. Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome. J. Exp Med 178:2097.
20. Li, L., W. A. Hagopian, R Brashear, T Daniels, and A. Lernmark 1993. Identification of autoantibody epitopes of glutamic acid decarboxylase in stiff-man syndrome patients. J. Immunol. 152:930.
21. Kim, J., M. Manchuk, T. Bugawan, Q. Fu, M. Jaffe, Y. Shi, H. J. Aanstoot, C. W. Turck, H. Erlich, V. Lennon, and S. Baekkeskov. 1994. Higher titer autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen, GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J. Exp. Med. 180.595
22. Richter, W., Y. Shi, and S. Baekkeskov 1993. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proc. Natl. Acad. Sci. USA 90:2832.
23. Ujihara, N., K Daw, R. Gianani, E. Boel, L. Yu, and A. C. Powers. 1994. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes. Diabetes 43:968.
24. Chang, Y, C., and D, L. Gottlieb. 1988 Characterization of the proteins purified with monoclonal antibodies to glutamic acid decarboxylase. J. Neurosci. 8:2123.
25. Mugnaini, E , and A. L. Dahl. 1983. Zinc-aldehyde fixation for light-microscopic immunocytochemistry of nervous tissue J Histochem. Cytochem. 31:1435.
26. Christgau, S., H. Schierbeck, H. J. Aanstoot, L Aagaard, K. Begley, H. Kofod, K. Hejnaes, and S. Baekkeskov 1991. Pancreatic beta cells express two autoantigenic forms of glutamic acid decarboxylase, a 65-kDa hydrophilic form and a 64-kDa amphiphilic form which can be both membrane-bound and soluble [published erratum appears in J. Biol. Chem. 1991;266(34) 23516]. J. Biol. Chem. 266:21257
27. Grubin, C. E., T Daniels, B. Toivola, M. Landin-Olsson, W. A. Hagopian, L. Li, A. E. Karlsen, E Boel, B. Michelsen, and A. Lernmark. 1994. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37:344.
28. Jackson, R. J., and T. Hunt. 1983. Preparation and use of nuclease-treated rabbit reticulocyte lysates for the translation of eukaryotic messenger RNA. Methods Enzymol. 96:50.
29. Schmidli, R. S., P. G. Colman, E. Bonifacio, G. F. Bottazzo, and L. C. Harrison. 1994. High level of concordance between assays for glutamic acid decarboxylase antibodies the first international glutamic acid decarboxylase antibody workshop Diabetes 43.1005.
30. Schmidli, R. S., P. G. Colman, and E. Bonifacio. 1995. Disease sensitivity and specificity of fifty-two assays for glutamic acid decarboxylase antibodies: the second international glutamic acid decarboxylase antibody workshop. Diabetes 44:636
31. r isoform of glutamic acid decarboxylase. Diabetes 42:631.
32. Velloso, L A., O. Kampe, A Hallberg, L Christmanson, C. Betsholtz, and F. A. Karlsson. 1993. Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in Type I diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression. J. Clin. Invest. 91:2084.
33. Daw, K., and A. C. Powers. 1995. Two distinct glutamic acid decarboxylase autoantibody specificities in IDDM target different epitopes. Diabetes 44:216.
34. Genovese, S., E Bonifacio, J. M. McNally, B. M Dean, R. Wagner, E. Bosi, E. A. Gale, and G. F. Bottazzo. 1992 Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:385.
35. Gianani, R., A. Pugliese, S. Bonner-Weir, A J. Shiffrin, J. S Soeldner, H. Erlich, Z. Awdeh, C A. Alper, R A Jackson, and G. S. Eisenbarth. 1992 Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes. Diabetes 41:347